The Harmful Role of C5a on Innate Immunity in Sepsis
- 26 June 2010
- journal article
- review article
- Published by S. Karger AG in Journal of Innate Immunity
- Vol. 2 (5), 439-445
- https://doi.org/10.1159/000317194
Abstract
There is accumulating evidence in humans and in experimental sepsis that robust activation of the complement system occurs along with development of defects in the innate immune system. In this report we review evidence that the complement activation product, C5a, appears in the plasma of rodents following cecal ligation and puncture (CLP). C5a interacts with its receptors (C5aR, C5L2) on phagocytes (polymorphonuclear neutrophils, PMNs, macrophages), ultimately paralyzing the ERK1/2 pathway of the mitogen-activated protein kinase signaling pathway. C5a is also interactive with its receptors on a variety of other cell types in various organs. Interaction of C5a with receptors on PMNs results in compromised innate immunity, with intense suppression of phagocytosis, chemotaxis and the respiratory burst. Endothelial cells acquire a pro-inflammatory phenotype (increased ICAM-1 and tissue factor expression), while macrophages are primed and produce large amounts of cytokines/chemokines. All of these outcomes are C5a and C5a receptor dependent. CLP also unleashes activation of clotting (and fibrinolytic) factors in a C5a-dependent manner. Finally, thymocytes upregulate C5aR and react with C5a, resulting in apoptosis via the intrinsic (mitochondrial) pathway. Collectively, these findings suggest that interception of C5a in sepsis preserves innate immune functions and may be a strategy for treatment of septic humans.Keywords
This publication has 33 references indexed in Scilit:
- Disturbed Homeostasis of Lung Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 During SepsisThe American Journal of Pathology, 2004
- Regulatory role of C5a in LPS‐induced IL‐6 production by neutrophils during sepsisThe FASEB Journal, 2003
- C5L2, a Nonsignaling C5A Binding ProteinBiochemistry, 2003
- Protective effects of anti‐C5a peptide antibodies in experimental sepsisThe FASEB Journal, 2001
- Role of C5a in Multiorgan Failure During SepsisThe Journal of Immunology, 2001
- Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5aJournal of Medicinal Chemistry, 1999
- Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function.1994
- Complement levels in septic primates treated with anti-C5a antibodiesJournal of Surgical Research, 1989
- Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.JCI Insight, 1986
- Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.1981